Hormone Therapy in Breast and Prostate Cancer (eBook, PDF)
79,72 €
inkl. MwSt.
Sofort per Download lieferbar
Hormone Therapy in Breast and Prostate Cancer (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Upload möglich
Andere Kunden interessierten sich auch für
- Prostate Cancer (eBook, PDF)149,79 €
- Hormonal Carcinogenesis IV (eBook, PDF)149,79 €
- Prostate Cancer Screening (eBook, PDF)213,99 €
- Prostate Cancer (eBook, PDF)110,95 €
- Molecular Basis of Thyroid Cancer (eBook, PDF)213,99 €
- Cancer Drug Resistance (eBook, PDF)213,99 €
- Sanchia S. GoonewardeneProstate Cancer Survivorship (eBook, PDF)96,29 €
-
-
-
This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer.
Produktdetails
- Produktdetails
- Verlag: Humana Press
- Erscheinungstermin: 5. Februar 2010
- Englisch
- ISBN-13: 9781592591527
- Artikelnr.: 37345163
- Verlag: Humana Press
- Erscheinungstermin: 5. Februar 2010
- Englisch
- ISBN-13: 9781592591527
- Artikelnr.: 37345163
An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer V. Craig Jordan and Barrington J. A. Furr Part I. Preclinical Antiestrogens Antiestrogens and the Cell Cycle Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove, and Robert L. Sutherland Drug Resistance to Antiestrogens Ruth M. O'Regan, Anait S. Levenson, Gale M. England, Kathy A. Yao, Henry D. Muenzner, Hiroyuki Takei, and V. Craig Jordan Mechanisms of Liver Carcinogenesis by Antiestrogens David H. Phillips The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat Yvonne P. Dragan and Henry C. Pitot Preclinical Studies of Raloxifene and Related Compounds Robin Fuchs-Young. Pure Antiestrogens, Alan E. Wakeling Part II. Antiestrogens: Clinical Tamoxifen for the Treatment of Breast Cancer V. Craig Jordan Clinical Utility of New Antiestrogens Ruth M. O'Regan and William J. Gradishar Breast Cancer Prevention with Antiestrogens Monica Morrow and V. Craig Jordan Part III. Inhibition of Estrogen Synthesis Aromatase Inhibitors Paul E. Goss and Caroline C. Reid Clinical Utility of Aromatase Inhibitors K. Shenton, Mitchell Dowsett, and Michael Dukes LH-RH Agonists for the Treatment of Breast Cancer: Development and Current Status Roger W. Blamey Part IV. Androgen and Androgen Withdrawal Molecular Action of Androgens Shutsung Liao, Junichi Fukuchi, and Yung-Hsi Kao Steroidal Antiandrogens Fritz H. Schröder and Albert Radlmaier Nonsteroidal Antiandrogens Geert J. C. M. Kolvenbag and Barrington J. A. Furr LH-RH Agonist Role in Prostate Cancer Management Amir V. Kaisary Part V. Perspective on Progress Recent Progress in Breast Cancer Research V. Craig Jordan and Barrington J. A. Furr
An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer V. Craig Jordan and Barrington J. A. Furr Part I. Preclinical Antiestrogens Antiestrogens and the Cell Cycle Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove, and Robert L. Sutherland Drug Resistance to Antiestrogens Ruth M. O'Regan, Anait S. Levenson, Gale M. England, Kathy A. Yao, Henry D. Muenzner, Hiroyuki Takei, and V. Craig Jordan Mechanisms of Liver Carcinogenesis by Antiestrogens David H. Phillips The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat Yvonne P. Dragan and Henry C. Pitot Preclinical Studies of Raloxifene and Related Compounds Robin Fuchs-Young. Pure Antiestrogens, Alan E. Wakeling Part II. Antiestrogens: Clinical Tamoxifen for the Treatment of Breast Cancer V. Craig Jordan Clinical Utility of New Antiestrogens Ruth M. O'Regan and William J. Gradishar Breast Cancer Prevention with Antiestrogens Monica Morrow and V. Craig Jordan Part III. Inhibition of Estrogen Synthesis Aromatase Inhibitors Paul E. Goss and Caroline C. Reid Clinical Utility of Aromatase Inhibitors K. Shenton, Mitchell Dowsett, and Michael Dukes LH-RH Agonists for the Treatment of Breast Cancer: Development and Current Status Roger W. Blamey Part IV. Androgen and Androgen Withdrawal Molecular Action of Androgens Shutsung Liao, Junichi Fukuchi, and Yung-Hsi Kao Steroidal Antiandrogens Fritz H. Schröder and Albert Radlmaier Nonsteroidal Antiandrogens Geert J. C. M. Kolvenbag and Barrington J. A. Furr LH-RH Agonist Role in Prostate Cancer Management Amir V. Kaisary Part V. Perspective on Progress Recent Progress in Breast Cancer Research V. Craig Jordan and Barrington J. A. Furr